Efficacy profiling of structurally diverse cannabinoid receptor ligands across transducer-coupling assays
The full efficacy range of ligands at CB1 and CB2 (i.e., inverse agonists, neutral agonists, partial agonists, full agonists, and high-efficacy agonists) h